NEW DELHI: Bharat Biotech Ltd has partnered with University of Wisconsin–Madison and US-based company FluGen to develop a vaccine against covid-19.
The vaccine called ‘CoroFlu’ will be built on the backbone of FluGen's candidate -- M2SR -- wherein gene sequences from SARS-CoV2, the novel coronavirus, will be inserted into the vaccine candidate to provide additional immunity against covid-19, apart from influenza, Bharat Biotech Biotech said in a release.
Bharat Biotech will then scale-up production in Hyderabad for safety and efficacy testing in humans, following which CoroFlu could be in human clinical trials by the fall of 2020, the release said. “Bharat Biotech will manufacture the vaccine, conduct clinical trials, and prepare to